CD200 expression has been implicated in helping tumors evade immune responses by binding to its receptors on immune cells, such as natural killer cells and macrophages, leading to the CD200R-mediated suppression of immune activity against tumor cells and the consequential growth and metastasis of tumor cells [4,12,37,56]. This evidence concerns the gene CD200 and neoplasm.